Drug reference
faropenem
Carbapenem/Cephalosporin (β-Lactam antibiotic) · Antimycobacterial
Carbapenem/Cephalosporin (β-Lactam antibiotic)Antimycobacterial
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Faropenem possesses both carbapenem and cephalosporin structures and is effective against M. tuberculosis without a β-lactamase inhibitor, likely by interfering with bacterial cell wall synthesis.
Indications
tuberculosisRespiratory infectionsENT infectionsGenitourinary infectionsStrep. pneumoniae, H. influenzae, Moraxella catarrhalis (highly susceptible)
Side effects
Common
DiarrhoeaAbdominal painNauseaRashes
Drug interactions
9 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Related guidelines
Drug-resistant tuberculosis
RNTCP · Pulmonology · 2025
Extrapulmonary tuberculosis
ICMR · Infectious Diseases · 2022
Skin and soft tissue infections
IDSA · Infectious Diseases · 2010
Pulmonary tuberculosis
RNTCP · Infectious Disease · 2023
Childhood pneumonia and respiratory infection
MOHFW · Paediatrics · 2021
Ask House about faropenem
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: KD Tripathi 7e, Goodman & Gilman 14e·Updated: 2026-05-10